Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03846830 · ClinicalTrials.gov registry record · NA

Incremental Velocity Error as a New Treatment in Vestibular Rehabilitation

A NA study of Mild Traumatic Brain Injury and Vestibular Neuropathy, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
24
Enrollment target
2
Study locations

NCT03846830: Completed NA study of Mild Traumatic Brain Injury and Vestibular Neuropathy, sponsored by Johns Hopkins University.

NCT03846830 is a NA study of Mild Traumatic Brain Injury and Vestibular Neuropathy that has completed, run by Johns Hopkins University. The registered enrollment target is 24 participants, below the 220-participant average among 43 other Mild Traumatic Brain Injury trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03846830, a NA study of Mild Traumatic Brain Injury and Vestibular Neuropathy, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
24 participants
Enrollment target
2
Study locations

Study Summary

The objective for this study is to compare outcome measures from vestibular rehabilitation (VPT) delivered in a traditional method against a new device Incremental Velocity Error (IVE) that improves physiologic performance of the vestibulo-ocular reflex. Participants include active duty service members with mild traumatic brain injury (mTBI) and civilians with peripheral vestibular hypofunction. The investigators will use a clinical trial cross-over design with randomization to either the control (VPT) or experimental (IVE) group and measure vestibulo-ocular reflex function as well as subjective and functional outcomes in order to investigate the best means to improve delivery of vestibular rehabilitation.

Primary Outcome

A ratio of eye/head velocity measured using a small video camera attached to a lightweight headband. This is an off-the-shelf device commonly used in clinic. Scores typically vary between 0 and 1.2 and normal ranges are between 0.8 and 1.2.

Interventions

  • DEVICE Incremental Velocity Error (IVE)
  • BEHAVIORAL Traditional Vestibular Rehabilitation (VPT)

Study Locations (2)

Maryland

  • Johns Hopkins University - Baltimore

Virginia

  • Fort Belvoir CH - Fort Belvoir

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2021-10-11
Est. Completion 2025-04-01
Phase NA
Johns Hopkins University

1,448 total trials

What the finished NCT03846830 record still lists

NCT03846830 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 220-participant average among 43 other Mild Traumatic Brain Injury trials with a reported enrollment target (89% lower).

The record links to 2 conditions, with Mild Traumatic Brain Injury appearing as the primary indexed condition, and to 2 interventions - of which Incremental Velocity Error (IVE) is the first listed.

NCT03846830 reports a single indexed study location in Maryland, Virginia.

Frequently Asked Questions

What is clinical trial NCT03846830 about?

NCT03846830 is a clinical study titled "Incremental Velocity Error as a New Treatment in Vestibular Rehabilitation". The objective for this study is to compare outcome measures from vestibular rehabilitation (VPT) delivered in a traditional method against a new device Incremental Velocity Error (IVE) that improves physiologic performance of the vestibulo-ocular reflex. Participants include active duty service memb...

What is the current status of trial NCT03846830?

This trial is currently completed. It is a NA study. The enrollment target is 24 participants. The study started on 2021-10-11. Estimated completion is 2025-04-01.

What conditions does trial NCT03846830 study?

This clinical trial studies the following conditions: Mild Traumatic Brain Injury, Vestibular Neuropathy.

What interventions are being tested in trial NCT03846830?

The interventions under investigation include: Incremental Velocity Error (IVE) (DEVICE), Traditional Vestibular Rehabilitation (VPT) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03846830?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03846830 being conducted?

This trial has 2 study locations across Maryland, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Mild Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03846830's enrollment target sits among peer trials

24 39th of 43 higher than 5 of 43 other Mild Traumatic Brain Injury trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Mild Traumatic Brain Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03846830, the US trial registry maintained by the National Library of Medicine. NCT03846830 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.